Boston Family Office’s Dentsply Sirona XRAY Stock Holding History

Boston Family Office’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,489	Closed	-$500K	–	264
2023 Q2	$500K	Hold	12,489	–	–	0.04%	192
2023 Q1	$490K	Hold	12,489	–	–	0.04%	191
2022 Q4	$398K	Sell	12,489 -1,500	-11%	-$45.2K	0.03%	212
2022 Q3	$396K	Sell	13,989 -8,395	-38%	-$287K	0.04%	208
2022 Q2	$800K	Hold	22,384	–	–	0.07%	160
2022 Q1	$1.1M	Sell	22,384 -100	-0.4%	-$5.29K	0.08%	150
2021 Q4	$1.25M	Hold	22,484	–	–	0.08%	149
2021 Q3	$1.3M	Sell	22,484 -359	-2%	-$22.1K	0.09%	143
2021 Q2	$1.45M	Hold	22,843	–	–	0.1%	140
2021 Q1	$1.46M	Sell	22,843 -297	-1%	-$17.2K	0.11%	138
2020 Q4	$1.21M	Sell	23,140 -722	-3%	-$35.6K	0.09%	146
2020 Q3	$1.04M	Sell	23,862 -11,100	-32%	-$491K	0.09%	143
2020 Q2	$1.54M	Sell	34,962 -561	-2%	-$23.7K	0.15%	119
2020 Q1	$1.38M	Sell	35,523 -268	-0.7%	-$13.7K	0.16%	115
2019 Q4	$2.02M	Hold	35,791	–	–	0.19%	107
2019 Q3	$1.91M	Sell	35,791 -100	-0.3%	-$5.37K	0.2%	109
2019 Q2	$2.1M	Hold	35,891	–	–	0.22%	101
2019 Q1	$1.78M	Sell	35,891 -2,837	-7%	-$125K	0.19%	112
2018 Q4	$1.44M	Sell	38,728 -8,074	-17%	-$294K	0.18%	118
2018 Q3	$1.77M	Sell	46,802 -6,143	-12%	-$256K	0.19%	123
2018 Q2	$2.32M	Sell	52,945 -17,480	-25%	-$821K	0.26%	99
2018 Q1	$3.54M	Sell	70,425 -1,000	-1%	-$58.9K	0.4%	80
2017 Q4	$4.7M	Buy	71,425 +1,300	+2%	+$82.7K	0.52%	67
2017 Q3	$4.19M	Sell	70,125 -4,340	-6%	-$258K	0.48%	69
2017 Q2	$4.83M	Sell	74,465 -210	-0.3%	-$13.3K	0.57%	61
2017 Q1	$4.66M	Sell	74,675 -1,980	-3%	-$119K	0.57%	60
2016 Q4	$4.42M	Sell	76,655 -700	-0.9%	-$41.4K	0.57%	57
2016 Q3	$4.6M	Sell	77,355 -2	-0%	-$123	0.6%	55
2016 Q2	$4.8M	Sell	77,357 -200	-0.3%	-$12.3K	0.62%	52
2016 Q1	$4.78M	Sell	77,557 -1,592	-2%	-$93.8K	0.63%	50
2015 Q4	$4.82M	Sell	79,149 -400	-0.5%	-$23.8K	0.66%	50
2015 Q3	$4.02M	Sell	79,549 -800	-1%	-$42.6K	0.56%	59
2015 Q2	$4.14M	Sell	80,349 -7,160	-8%	-$371K	0.52%	64
2015 Q1	$4.45M	Sell	87,509 -1,300	-1%	-$67K	0.55%	61
2014 Q4	$4.73M	Sell	88,809 -5,850	-6%	-$298K	0.59%	54
2014 Q3	$4.32M	Sell	94,659 -420	-0.4%	-$19.8K	0.56%	56
2014 Q2	$4.5M	Sell	95,079 -3,690	-4%	-$172K	0.57%	54
2014 Q1	$4.55M	Hold	98,769	–	–	0.6%	53
2013 Q4	$4.79M	Sell	98,769 -200	-0.2%	-$9.36K	0.63%	52
2013 Q3	$4.3M	Sell	98,969 -800	-0.8%	-$34.1K	0.61%	54
2013 Q2	$4.09M	Buy	+99,769	New	+$4.16M	0.62%	53

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boston Family Office's XRAY Position: Q3 2023 in Review

Boston Family Office sold out of Dentsply Sirona (XRAY) in Q3 2023, closing a stake of 12,489 shares — an estimated $500K sold.

Boston Family Office first reported a position in XRAY in Q2 2013 and held it in 41 quarters. The position peaked at $4.83M in Q2 2017. 474 funds tracked by Wall St. Rank hold XRAY as of Q3 2023.

Boston Family Office reported no remaining Dentsply Sirona position as of Q3 2023 after selling out during the quarter.
Boston Family Office sold 12,489 Dentsply Sirona shares in Q3 2023, an estimated $500K.
Boston Family Office first reported a position in Dentsply Sirona in Q2 2013 and held it in 41 quarters.
Boston Family Office's Dentsply Sirona position peaked at $4.83M in Q2 2017.
474 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2023.

Based on Boston Family Office's 13F filing for Q3 2023, filed 13 Nov 2023.